📚 Lecture Overview
This lecture covers the acute complications of diabetes mellitus, including diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS), and hypoglycemia. Understanding these emergencies is critical because they are life-threatening conditions requiring rapid diagnosis, targeted fluid and electrolyte management, and precise insulin therapy to prevent fatal outcomes.
🎯 Key Concepts & Definitions
- Diabetic Ketoacidosis (DKA): An acute, life-threatening complication primarily in Type 1 diabetes characterized by hyperglycemia (>250 mg/dL), high anion gap metabolic acidosis (pH <7.3, HCO3 <15 mEq/L), and ketonemia.
- Hyperglycemic Hyperosmolar State (HHS): A severe complication usually seen in Type 2 diabetes featuring extreme hyperglycemia (>600 mg/dL), severe dehydration, and high serum osmolality (>310 mOsm/kg) without significant ketoacidosis.
- Hypoglycemia: A drop in blood glucose below 70 mg/dL accompanied by adrenergic or gastrointestinal symptoms, commonly caused by insulin or secretagogue overdose.
- Hypoglycemic Unawareness: A condition where repeated hypoglycemia blunts autonomic warning symptoms, causing neuroglycopenia to become the initial warning sign.
- Anion Gap: The difference between measured cations and anions; elevated in DKA due to the accumulation of unmeasured ketoacid anions.
📖 Main Content
1. Diabetic Ketoacidosis (DKA) Pathogenesis & Diagnosis
- Pathogenesis: Absolute insulin deficiency combined with excess counter-regulatory hormones (glucagon, catecholamines, growth hormone) leads to:
- Gluconeogenesis: Protein breakdown yielding amino acids converted to glucose.
- Glycogenolysis: Breakdown of liver glycogen into glucose.
- Lipolysis: Hepatic fatty acid oxidation forming ketone bodies (beta-hydroxybutyrate, acetoacetate, acetone), causing ketonemia and high anion gap metabolic acidosis.
- Classic Diagnostic Criteria:
- Plasma glucose > 250 mg/dL
- Arterial pH < 7.30 or serum bicarbonate < 15 mEq/L
- Positive serum ketones
- Clinical Findings: Polyuria, polydipsia, nausea, vomiting, abdominal pain, Kussmaul respirations (rapid deep breathing), and a fruity acetone breath odor. Patients are typically hypothermic unless an infection is present.
- Laboratory Pearls:
- Hyperkalemia is common despite total body potassium depletion due to extracellular shifts caused by acidosis.
- Standard nitroprusside tests detect acetoacetate and acetone but miss beta-hydroxybutyrate (the predominant ketone in DKA).
2. DKA Management
- Fluid Replacement:
- Initial fluid deficit is typically 4–5 liters.
- Infuse 0.9% normal saline rapidly (1 L/h over the first 1-2 hours).
- Switch to 5% dextrose containing solutions once blood glucose drops to 250 mg/dL to prevent hypoglycemia and cerebral edema.
- Insulin Replacement:
- Give an initial IV regular insulin bolus of 0.1 unit/kg, followed by a continuous infusion of 0.1 unit/kg/h.
- Potassium Management:
- Add 10-30 mEq/h of potassium chloride to IV fluids.
- Postpone potassium if serum K+ is > 5 mEq/L. Delay insulin if serum K+ is < 3.5 mEq/L until corrected.
- Sodium Bicarbonate:
- Reserved only for severe acidosis where arterial pH is 7.0 or less to avoid complications like hypokalemia, tissue anoxia, and cerebral acidosis.
3. Hyperglycemic Hyperosmolar State (HHS)
- Essentials of Diagnosis:
- Hyperglycemia > 600 mg/dL (often 800–2400 mg/dL)
- Serum osmolality > 310 mOsm/kg
- No significant acidosis (pH > 7.3, HCO3 > 15 mEq/L)
- Pathogenesis: Relative insulin deficiency prevents significant ketogenesis (enough insulin to stop lipolysis, not enough to control glucose) while causing massive glycosuria and profound dehydration (fluid deficit 6-10 L).
- Treatment Strategy:
- Aggressive fluid replacement with 0.45% saline (or 0.9% if hypotensive/oliguric).
- Lower insulin requirements than DKA: start infusion at 0.05 unit/kg/h (no bolus needed).
4. Hypoglycemia & Drug-Induced Complications
- Symptom Progression:
- Autonomic/Sympathetic symptoms start around 54 mg/dL (tachycardia, sweating, tremors, palpitations, nausea).
- Neuroglycopenic symptoms appear around 50 mg/dL or lower (confusion, blurred vision, headache, slurred speech, seizures, coma).
- Precipitating Factors: Excessive insulin dosing, missed meals, alcohol consumption on an empty stomach, exercise, and "stacking" insulin doses. Beta-blockers can mask adrenergic symptoms (except sweating).
- Treatment:
- Conscious patients: Ingest 15 grams of fast-acting carbohydrates (glucose tablets or juice), recheck in 15 minutes.
- Unconscious patients: 1 mg Glucagon (IM/SC or nasal spray) or 50 mL of 50% IV glucose.
📊 Visual Learning
flowchart TD
A["Insulin Deficiency"] --> B["Hyperglycemia"]
A --> C["Lipolysis"]
B --> D["Polyuria and Dehydration"]
C --> E["Ketone Production"]
E --> F["Metabolic Acidosis"]
F --> G["Kussmaul Respiration"]
mindmap
root("Acute Diabetes Complications")
"DKA"
"Glucose > 250"
"pH < 7.3"
"Ketonemia"
"Kussmaul Breathing"
"HHS"
"Glucose > 600"
"Osmolality > 310"
"No Acidosis"
"Severe Dehydration"
"Hypoglycemia"
"Glucose < 70"
"Autonomic Symptoms"
"Neuroglycopenia"
"Treated with 15g Carbs"
graph LR
A[Initial Assessment] --> B{Check Blood Glucose}
B -->|> 250 mg/dL & Acidosis| C[Diagnose DKA]
B -->|> 600 mg/dL & High Osmolality| D[Diagnose HHS]
B -->|< 70 mg/dL| E[Diagnose Hypoglycemia]
C --> F[Fluids and Regular Insulin]
D --> G[Aggressive Fluids and Lower Insulin]
E --> H[Administer 15g Carbohydrates]
💡 Important Points to Remember
- DKA vs. HHS Key Split: DKA presents with rapid onset, ketosis, and metabolic acidosis (pH < 7.3). HHS presents with an insidious onset, extreme hyperglycemia (>600 mg/dL), profound hyperosmolality (>310 mOsm/kg), and absent ketosis.
- Potassium Trap: Serum potassium in DKA may look normal or high due to extracellular shifting from acidosis, despite total body depletion. Correcting acidosis drives potassium back into cells, risking fatal hypokalemia.
- The Beta-Hydroxybutyrate Blindspot: Standard bedside nitroprusside strips detect acetoacetate and acetone, but fail to measure beta-hydroxybutyrate, risking false-negative ketone readings.
- Fluid Transition Rule: In both DKA and HHS, once blood glucose falls to 250 mg/dL, switch IV fluids to contain 5% dextrose to prevent rapid drops that cause cerebral edema.
- Sodium Correction Formula: Serum sodium decreases by 1.6 mEq/L for every 100 mg/dL increase in plasma glucose.
- Bicarbonate Restriction: Sodium bicarbonate in DKA should only be given if arterial pH is $≤$ 7.0.
- Insulin Infusion Doses: DKA uses a 0.1 unit/kg bolus followed by 0.1 unit/kg/h. HHS skips the bolus and uses a lower infusion rate of 0.05 unit/kg/h.
- Hypoglycemic Unawareness: Repeated low blood glucose blunts warning symptoms, causing neuroglycopenic signs to appear before autonomic ones.
- Beta-Blocker Caution: Beta-blockers blunt most adrenergic warning signs of hypoglycemia, except for sweating.
⚠️ Common Exam Questions
- Classic MCQ Trap 1: An examiner will state a patient has normal/low serum potassium in DKA and ask whether to supplement immediately or withhold. Trick: Even if serum K+ looks normal, total body potassium is depleted; if K+ is < 5 mEq/L, you must replace it. If K+ is < 3.5 mEq/L, withhold insulin until corrected.
- Classic MCQ Trap 2: Testing diagnostic cutoffs. Students confuse the glucose cutoff for DKA (>250 mg/dL) with HHS (>600 mg/dL) or Hypoglycemia (<70 mg/dL).
- Short-Answer Question: "Why is ketosis absent in HHS despite severe insulin deficiency?" Expected Answer: Because a low/residual level of insulin remains—just enough to inhibit hepatic lipolysis and ketogenesis, but not enough to control blood glucose or prevent massive glycosuria and dehydration.
- Diagnostic Trick: A patient presents with a negative bedside nitroprusside urine/blood ketone test, but has a high anion gap metabolic acidosis. Why? The predominant ketone body is beta-hydroxybutyrate, which nitroprusside reagents do not detect.
📝 Quick Review Checklist
I can differentiate the diagnostic criteria of DKA and HHS
I understand why hyperkalemia occurs in DKA despite total body potassium depletion
I can explain the pathogenesis of metabolic ketoacidosis and lipolysis
I know the correct fluid management strategy when blood glucose reaches 250 mg/dL
I know when sodium bicarbonate is indicated in DKA treatment
I can distinguish between autonomic and neuroglycopenic symptoms of hypoglycemia
I understand the concept of hypoglycemic unawareness and beta-blocker interference
I know the initial insulin infusion rates for both DKA and HHS